Trials / Unknown
UnknownNCT03887806
Cost Effectiveness Analysis of an Ancillary Study of the REMOTEV Study
Efficacy Cost Analysis: Retrospective Study on the REMOTEV Study's Ancillary Data
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The implications of the medico-economic impact are essential in the choice of first-line therapists. The economic impact is an important criterion to recommend the privileged use of Direct Oral Anticoagulants (AOD) in first intention.
Conditions
Timeline
- Start date
- 2019-03-20
- Primary completion
- 2020-03-20
- Completion
- 2020-03-20
- First posted
- 2019-03-25
- Last updated
- 2019-03-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03887806. Inclusion in this directory is not an endorsement.